Psychometric Properties of the Center for Epidemiologic Studies-Depression Scale in Multiple SclerosisVerdier-Taillefer M.-H. · Gourlet V. · Fuhrer R. · Alpérovitch A.
INSERM U360, Hôpital la Salpêtrière, Paris, France
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
The factorial structure of the Center for Epidemiologic Studies-Depression (CES-D) scale has been examined on a large sample of multiple sclerosis (MS) subjects (n = 696), general practice patients (n = 1,308) and healthy workers (n = 342). The aim of this study was to verify if the CES-D is a valid and reliable scale to assess depressive symptomatology in MS. As previously reported in the literature, we found four factors that measure depressed affect, positive affect, somatic complaints or retarded activity and interpersonal relationships. The percent of total variance explained by the four factors was greater than 50% in each group. Cronbach’s α coefficients were 0.90 in the MS sample and 0.93 in the general practice sample, indicative of high reliability in both samples. From these results, we conclude that the CES-D can be used to screen for depression in epidemiological studies of this psychiatric disorder among MS patients.
© 2001 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.